|
| 30444282 | Special issue on stem cell and tissue engineering in development, disease, and repair. | Dev Dyn | 2019 |
| 30656618 | Making NSC and Neurons from Patient-Derived Tissue Samples. | Methods Mol Biol | 2019 |
| 30669334 | The Future State of Newborn Stem Cell Banking. | J Clin Med | 2019 |
| 29600249 | Human-Induced Pluripotent Stem Cells Manufactured Using a Current Good Manufacturing Practice-Compliant Process Differentiate Into Clinically Relevant Cells From Three Germ Layers. | Front Med (Lausanne) | 2018 |
| 30004605 | Repurposing the Cord Blood Bank for Haplobanking of HLA-Homozygous iPSCs and Their Usefulness to Multiple Populations. | Stem Cells | 2018 |
| 29793831 | Illustrating the potency of current Good Manufacturing Practice-compliant induced pluripotent stem cell lines as a source of multiple cell lineages using standardized protocols. | Cytotherapy | 2018 |
| 28353266 | Derivation of Human-Induced Pluripotent Stem Cells in Chemically Defined Medium. | Methods Mol Biol | 2017 |
| 28191759 | Heparin Promotes Cardiac Differentiation of Human Pluripotent Stem Cells in Chemically Defined Albumin-Free Medium, Enabling Consistent Manufacture of Cardiomyocytes. | Stem Cells Transl Med | 2017 |
| 24615461 | Genetic Modification in Human Pluripotent Stem Cells by Homologous Recombination and CRISPR/Cas9 System. | Methods Mol Biol | 2016 |
| 26254731 | Comparative neurotoxicity screening in human iPSC-derived neural stem cells, neurons and astrocytes. | Brain Res | 2016 |
| 27116668 | Treatment Paradigms for Retinal and Macular Diseases Using 3-D Retina Cultures Derived From Human Reporter Pluripotent Stem Cell Lines. | Invest Ophthalmol Vis Sci | 2016 |
| 27382370 | Manufacturing Cells for Clinical Use. | Stem Cells Int | 2016 |
| 27191603 | Derivation, Characterization, and Neural Differentiation of Integration-Free Induced Pluripotent Stem Cell Lines from Parkinson's Disease Patients Carrying SNCA, LRRK2, PARK2, and GBA Mutations. | PLoS One | 2016 |
| 27283945 | Detailed Characterization of Human Induced Pluripotent Stem Cells Manufactured for Therapeutic Applications. | Stem Cell Rev Rep | 2016 |
| 27185282 | Setting Global Standards for Stem Cell Research and Clinical Translation: The 2016 ISSCR Guidelines. | Stem Cell Reports | 2016 |
| 26718646 | Developing Induced Pluripotent Stem Cell-Based Therapy for the Masses. | Stem Cells Transl Med | 2016 |
| 27034412 | High-Throughput Phenotypic Screening of Human Astrocytes to Identify Compounds That Protect Against Oxidative Stress. | Stem Cells Transl Med | 2016 |
| 26704439 | Accelerating stem cell trials for Alzheimer's disease. | Lancet Neurol | 2016 |
| 26892726 | Whole-genome mutational burden analysis of three pluripotency induction methods. | Nat Commun | 2016 |
| 26239912 | Regenerative cellular therapies for neurologic diseases. | Brain Res | 2016 |
| 25091426 | Motor neuron differentiation from pluripotent stem cells and other intermediate proliferative precursors that can be discriminated by lineage specific reporters. | Stem Cell Rev Rep | 2015 |
| 31245438 | Xenogeneic-free defined conditions for derivation and expansion of human embryonic stem cells with mesenchymal stem cells. | Regen Ther | 2015 |
| 26414932 | Human Induced Pluripotent Stem Cell NEUROG2 Dual Knockin Reporter Lines Generated by the CRISPR/Cas9 System. | Stem Cells Dev | 2015 |
| 26411904 | cGMP-Manufactured Human Induced Pluripotent Stem Cells Are Available for Pre-clinical and Clinical Applications. | Stem Cell Reports | 2015 |
| 26276001 | Research using Mesenchymal Stem/Stromal Cells: quality metric towards developing a reference material. | Cytotherapy | 2015 |
| 26235913 | Transcriptome Dynamics of Developing Photoreceptors in Three-Dimensional Retina Cultures Recapitulates Temporal Sequence of Human Cone and Rod Differentiation Revealing Cell Surface Markers and Gene Networks. | Stem Cells | 2015 |
| 26066579 | A cost-effective and efficient reprogramming platform for large-scale production of integration-free human induced pluripotent stem cells in chemically defined culture. | Sci Rep | 2015 |
| 25843045 | Mitochondrial alterations by PARKIN in dopaminergic neurons using PARK2 patient-specific and PARK2 knockout isogenic iPSC lines. | Stem Cell Reports | 2015 |
| 25835482 | Cell therapy worldwide: an incipient revolution. | Regen Med | 2015 |
| 25939939 | National Institutes of Health: a catalyst in advancing regenerative medicine science into practice. | Mayo Clin Proc | 2015 |
| 25933231 | Development of a global network of induced pluripotent stem cell haplobanks. | Regen Med | 2015 |
| 25951995 | Rapid and Efficient Generation of Transgene-Free iPSC from a Small Volume of Cryopreserved Blood. | Stem Cell Rev Rep | 2015 |
| 25650438 | Enabling consistency in pluripotent stem cell-derived products for research and development and clinical applications through material standards. | Stem Cells Transl Med | 2015 |
| 25637190 | Rescue of an in vitro neuron phenotype identified in Niemann-Pick disease, type C1 induced pluripotent stem cell-derived neurons by modulating the WNT pathway and calcium signaling. | Stem Cells Transl Med | 2015 |
| 25777362 | A platform for rapid generation of single and multiplexed reporters in human iPSC lines. | Sci Rep | 2015 |
| 25722426 | Concise review: making and using clinically compliant pluripotent stem cell lines. | Stem Cells Transl Med | 2015 |
| 25770678 | Can cord blood banks transform into induced pluripotent stem cell banks? | Cytotherapy | 2015 |
| 25741760 | Transfection, selection, and colony-picking of human induced pluripotent stem cells TALEN-targeted with a GFP gene into the AAVS1 safe harbor. | J Vis Exp | 2015 |
| 25794298 | Induced Pluripotent Stem Cell Models to Enable In Vitro Models for Screening in the Central Nervous System. | Stem Cells Dev | 2015 |
| 25476796 | Preclinical biosafety evaluation of cell-based therapies: emerging global paradigms. | Toxicol Pathol | 2015 |
| 25575079 | Generating iPSCs: translating cell reprogramming science into scalable and robust biomanufacturing strategies. | Cell Stem Cell | 2015 |
| 25516409 | Banking on iPSC--is it doable and is it worthwhile. | Stem Cell Rev Rep | 2015 |
| 25614444 | Need for DISCUSS(ion). | Stem Cells Transl Med | 2015 |
| 25587899 | Transcription activator-like effector nuclease (TALEN)-mediated CLYBL targeting enables enhanced transgene expression and one-step generation of dual reporter human induced pluripotent stem cell (iPSC) and neural stem cell (NSC) lines. | PLoS One | 2015 |
| 24019252 | Functional screening assays with neurons generated from pluripotent stem cell-derived neural stem cells. | J Biomol Screen | 2014 |
| 25496616 | International coordination of large-scale human induced pluripotent stem cell initiatives: Wellcome Trust and ISSCR workshops white paper. | Stem Cell Reports | 2014 |
| 25456120 | iPSC-derived dopamine neurons reveal differences between monozygotic twins discordant for Parkinson's disease. | Cell Rep | 2014 |
| 25454721 | Compounds with species and cell type specific toxicity identified in a 2000 compound drug screen of neural stem cells and rat mixed cortical neurons. | Neurotoxicology | 2014 |
| 25368377 | Concise review: modeling central nervous system diseases using induced pluripotent stem cells. | Stem Cells Transl Med | 2014 |
| 25065637 | Survival and engraftment of dopaminergic neurons manufactured by a Good Manufacturing Practice-compatible process. | Cytotherapy | 2014 |